Midazolam Hydrochloride

7 trials 4 recruiting NNeurology/Psychiatry

Filter these 7 trials by condition, phase, country and more.

Open in Search →

7 Registered trials

4 Recruiting

1 Completed trials

7 Sponsors

6 Countries

Phase III

Phase II

Phase I/II

Phase IV

Phase III: 2 Phase II: 2 Phase I/II: 1 Phase IV: 2

Oversight events:

3 serious breaches 1 temporary halt across 1 trial

View oversight register →

Indications tested

Alcohol use disorder 1 Substance use disorder 1

Sponsors using this IMP

Akershus University Hospital 1 Amsterdam UMC 1 Consorci Mar Parc De Salut De Barcelona 1 Heidelberg University Hospital AöR 1 Herlev Hospital 1 Medical University Of Vienna 1 University Hospital Of North Norway HF 1

All trials

7 total

Pharmacokinetic Profiles of Subcutaneous vs. Intravenous Midazolam in Terminally Ill Patients in Palliative Care (PK-MID-PAL-study) Pending

2025-521082-26-00 Phase II 1 country Akershus University Hospital
Evaluation of the persistency of the preoperative anxiolytic effect of music therapy vs midazolam: electroencephalographic and clinical ana… Pending

2025-522575-29-00 Phase IV 1 country Consorci Mar Parc De Salut De Barcelona
FORE-PAIN trial Recruiting

2022-500176-63-00 Phase III 1 country Amsterdam UMC
Ketamine for depression and alcohol use disorder Recruiting

2023-506052-24-00 Phase I/II 1 country University Hospital Of North Norway HF
Long-term neuropsychologic outcome of pre-emptive mTOR inhibitor treatment in children with tuberous sclerosis complex (TSC) under 4 months … Recruiting

2022-502332-39-00 Phase II 2 countries Heidelberg University Hospital AöR
Ketamine therapy in obsessive-compulsive disorder and its effects on neuropsychological function under stress in a cross-over trial Recruiting

2024-518212-40-00 Phase III 1 country Medical University Of Vienna
Efficacy of Remimazolam with Fentanyl versus Midazolam with Fentanyl Ended

2023-503470-21-00 Phase IV 1 country Herlev Hospital

Showing 1–7 of 7 trials

← All drugs A–Z